543 patents currently held
100 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
10 more records may belong here and await a decision; they are not counted.
The next term ends in Jan 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
52
Ending by 2030
Jan 2027
Next term end
469
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Aug 2036 · High confidence
Also notable
Ends Mar 2029 · High confidence
Also notable
Ends Jun 2033 · Medium confidence
Also notable
Ends Mar 2036 · High confidence
Also notable
Ends Feb 2038 · Medium confidence
Also notable
Ends Sep 2037 · High confidence
Also notable
Ends May 2034 · High confidence
Also notable
Ends Nov 2030 · High confidence
IL2R Common Gamma Chain Antibodies
US 10,696,747
Cited by 25 later US patents, top 10% of utility patents granted in 2020 in our data. Protection runs to 2036. A terminal disclaimer caps this term to an earlier patent's.
Microcarriers for Stem Cell Culture
US 9,458,431
Cited by 26 later US patents, top 25% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2029. A terminal disclaimer caps this term to an earlier patent's.
Bicyclic Heteroaryl Derivatives as MNK1 and MNK2 Modulators and Uses Thereof
US 10,280,168
Cited by 17 later US patents, top 25% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2033.
Anti-PD-L1 Antibodies
US 10,517,949
Cited by 20 later US patents, top 25% of utility patents granted in 2019 in our data. Protection runs to 2036.
Use of Pridopidine for the Treatment of Fragile X Syndrome
US 11,234,973
Granted 2022. Computed term ends 2038.
Anti-Dengue Virus Antibodies, Polypeptides Containing Variant FC Regions, and Methods of Use
US 10,844,113
A family of 8 related applications built on the 2020 grant. Protection runs to 2037.
IL-1BETA Neutralizing Human Monoclonal Antibodies
US 10,167,335
A family of 6 related applications built on the 2019 grant. Protection runs to 2034.
Mesenchymal Stem Cell Conditioned Medium
US 9,029,146
The largest patent family in this portfolio, 5 related applications, renewed at every maintenance window due so far. Protection runs to 2030.
Formerly held, still cited
Notable
Ends Sep 2037 · High confidence
Cited by 15 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2037.
now held by Chugai Seiyaku Kabushiki Kaisha
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Nov 23 to 28, 2026 · next Nov 23
- 8 fees due Dec 6 to 27, 2026 · next Dec 6
- 12 fees due Jan 4 to 30, 2027 · next Jan 4
- 5 fees due Feb 1 to 28, 2027 · next Feb 1
- 5 fees due Mar 3 to 26, 2027 · next Mar 3
- 10 fees due Apr 1 to 29, 2027 · next Apr 1
- 21 fees due May 3 to 21, 2027 · next May 3
- 13 fees due Jun 1 to 30, 2027 · next Jun 1
- 13 fees due Jul 2 to 28, 2027 · next Jul 2
- 9 fees due Aug 2 to 27, 2027 · next Aug 2
- 6 fees due Sep 1 to 24, 2027 · next Sep 1
- 9 fees due Oct 2 to 30, 2027 · next Oct 2
- 10 fees due Nov 3 to 19, 2027 · next Nov 3
Recent changes
- Nov 2Assignment recorded on 1 record: Lim, Teck Guan and 5 others to Agency for Science, Technology and Research Recorded Nov 2, 2026, executed Oct 15, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76589, frame 879.
- Oct 29Assignment recorded on 1 record: Soh, Jia Hao Eugene and 1 other to Agency for Science, Technology and Research Recorded Oct 29, 2026, executed Oct 5, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76557, frame 559.
- 16 of the patents on this record were granted since Aug 23, 2026
- 14 terms have ended since Aug 23, 2026
- Oct 30 US 10,111,787 Apparatus for a Diaper, a System, a Diaper and a Method of Manufacturing an Electrode · lapsed on the fee record
- Oct 23 US 10,107,748 Optical Sensing Device for Surface Plasmon Resonance (SPR) and Optical Sensing Method Using Surface Plasmon Resonance (SPR) · lapsed on the fee record
- Oct 16 US 10,103,359 Multilayer Film for Encapsulating Oxygen And/Or Moisture Sensitive Electronic Devices · lapsed on the fee record
- Oct 14 US 8,862,581 Method and System for Concentration Detection · lapsed on the fee record
- Oct 11 US 11,469,755 A Comparator for Controlling Dead-Time Between Switching Transistors · lapsed on the fee record
- Oct 7 US 8,853,330 Hybrid Polymers · lapsed on the fee record
- Sep 30 US 8,847,104 Wafer Cutting Method and a System Thereof · lapsed on the fee record
- Sep 25 US 10,080,644 Tissue Interface Augmentation Device for Ligament/Tendon Reconstruction · lapsed on the fee record
- Sep 11 US 10,071,183 Amphiphilic Linear Peptide/Peptoid and Hydrogel Comprising the Same · lapsed on the fee record
- Sep 9 US 8,829,765 Piezoelectric Actuator Device · lapsed on the fee record
- Sep 9 US 8,828,720 Microcarriers for Stem Cell Culture · lapsed on the fee record
- Sep 4 US 10,066,019 Optimised Heavy Chain and Light Chain Signal Peptides for the Production of Recombinant Antibody Therapeutics · lapsed on the fee record
- Sep 2 US 8,824,759 Correcting Axial Tilt Based on Object Positions in Axial Slices of Three Dimensional Image · lapsed on the fee record
- Aug 26 US 8,816,456 Magnetoresistive Device and a Method of Forming the Same · lapsed on the fee record
What they patent
The largest of its 469 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,368,265 | Selective Genome Amplification In force · High confidence | In force | High confidence | |
| US 7,822,456 | Locating a Mid-Sagittal Plane In force · High confidence | In force | High confidence | |
| US 9,581,527 | Apparatus for Processing a Sample in a Liquid Droplet and Method of Using the Same In force · Medium confidence | In force | Medium confidence | |
| US 7,598,104 | Method of Forming a Metal Contact and Passivation of a Semiconductor Feature In force · High confidence | In force | High confidence | |
| US 8,124,251 | Thin Films of Ferroelectric Materials and a Method for Preparing Same In force · High confidence | In force | High confidence | |
| US 8,261,598 | Apparatus for Performing a Reaction in a Droplet and Method of Using the Same In force · High confidence | In force | High confidence | |
| US 8,470,211 | Ferroelectric ceramic material with a low sintering temperature In force · High confidence | In force | High confidence | |
| US 7,709,542 | Proton-Exchange Composite Containing Nanoparticles Having Outer Oligomeric Ionomer, and Methods of Forming In force · High confidence | In force | High confidence | |
| US 8,278,725 | Micromechanical Structure and a Method of Fabricating a Micromechanical Structure In force · High confidence | In force | High confidence | |
| US 8,213,754 | Optical Splitter, Combiner and Device In force · High confidence | In force | High confidence |
Also on record, not counted in the 543: 100 patents in force now held by others · 935 patents ended · 347 applications pending · 1,078 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.